Targeting epigenetic mechanisms as an emerging therapeutic strategy in pulmonary hypertension disease [0.03%]
表观遗传机制在肺动脉高压治疗中的应用展望
Malik Bisserier,Radoslav Janostiak,Frank Lezoualc&#x;h et al.
Malik Bisserier et al.
Pulmonary arterial hypertension (PAH) is a multifactorial cardiopulmonary disease characterized by an elevation of pulmonary artery pressure (PAP) and pulmonary vascular resistance (PVR), which can lead to right ventricular (RV) failure, mu...